Koning Health develops breast imaging technology designed to give clinicians detailed three-dimensional views of breast tissue without compression. Its flagship product, the Koning Vera Breast CT, uses cone-beam computed tomography to produce high-resolution images, with scans taking less than 10 seconds per breast. The system is intended for diagnostic workups and can support 3D-guided biopsy, with or without contrast. Koning describes its radiation dose as comparable to diagnostic mammography; its biopsy imaging dose has also been reported as lower than that of stereotactic biopsy.

The technology is designed for a range of clinical uses, including evaluating dense or small breasts, implants, calcifications, and changes after surgery or treatment. Koning says its system can help clinicians assess breast tissue from multiple angles and support diagnosis and treatment planning. The company also provides information and resources for healthcare professionals and patients, including educational materials, publications, FAQs, reviews, and center locations. Koning reports more than two decades of cone-beam CT development, over 120 patents globally, and FDA PMA approval for the Koning Vera system and its 3D-guided biopsy.